Skip to main content
2024 Canadian Cardiovascular Congress Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Handout
Handout
Networking
Networking
On-Demand
On-Demand
Early Career Involvement
Early Career Involvement
Back
Session Evaluation

IMAGING

HEART FAILURE

EARLY CAREER INVOLVEMENT

165 - BACK TO BASICS: ROLE OF ECHOCARDIOGRAPHY IN THE DIAGNOSIS AND MANAGEMENT OF HEART FAILURE WITH REDUCED EJECTION FRACTION

Thursday, October 24, 2024
4:30 PM – 5:30 PM PT
Room: 212-213
Early Career Involvement
Workshop Description: Echocardiography is the workhorse for diagnosis, assessment, and follow-up of patients with heart failure (HF). While echocardiography can shed light on many aspects of HF care, many practitioners limit their use of echo to the estimation of ejection fraction. This is unfortunate as it is the most available and accessible test for HF evaluation. In this workshop, we aim to provide insight on the value of echocardiograms in diagnosing HF, in risk-stratification, in estimating the chronicity of the disease, the etiologies, and in prognostication. We explore adjunct modalities to 2D echocardiography, including 3D, strain, contrast imaging, and when to move to advanced imaging modalities. The workshop will be led by a trainee presenting a case then enriched with discussion between panelists and involving audience.
A highlight of the workshop is the exploration of the use of point-of-care ultrasound in HF patient management. This technique is underutilized likely due to lack of awareness of the potential role POCUS can play in HF management.

Interactive and Engagement Activities Description: Several strategies will be deployed to engage participants and promote active learning. These will include live polling via the Audience Response System (ARS), allowing real-time feedback and encouraging interaction among presenters and between presenters, chairs, and the audience. Panel discussions will provide diverse perspectives on key topics. The question and answer period facilitated by the co-chairs will inspire debate between panel members and the audience about critical topics to encourage participants to reflect on the content and encourage discussion.

Learning Objectives:

At the end of this session participants will be able to:
  • identify features in a standard echocardiogram that reflect the chronicity, the risk, and potential etiology of cardiomyopathy;
  • define about the role of 3-Dimensional echocardiogram and strain imaging in cardiomyopathy assessment (including differentiating athlete's heart from cardiomyopathy);
  • understand the role of contrast echocardiography (current and emerging uses) in evaluating patients with cardiomyopathy, and when to move to advancing imaging; and
  • identify the role of point-of-care ultrasound and echocardiography in guiding acute management of HF patients (including estimating filling pressures, cardiac output, and pulmonary pressures).
Disclosure(s):
Stephanie Poon, MD: Bayer: Member of speaker's bureau (Ongoing); Boehringer Ingelheim: Member of heart failure advisory board (Ongoing), previous research grant (Ongoing); GSK: Member of advisory board and speaker's bureau (Ongoing); Servier: Member of national heart failure advisory board and speaker's bureaus (Terminated, January 1, 2024)
Aws Almufleh, MBBS, MPH, FRCPC, FASE, FACC: Boehringer Ingelheim: Speaker honoraria (Ongoing); Novartis: Quality improvement project (Terminated, November 16, 2023); Novo Nordisk: Consultant/Advisory Board (Terminated, May 29, 2024); Pfizer: Advisory board (Ongoing), Quality improvement project (Ongoing), Speaker honoraria (Ongoing)
Omid Kiamanesh, MD, FRCPC: No financial relationships to disclose
Benedicte Lefebvre, MD, CM, FACC, FASE: No financial relationships to disclose
David Ian Paterson, MD, FRCPC: No financial relationships to disclose
Haya Aziz, MD, FRCPC: No financial relationships to disclose
Robin A. Ducas, MD, FRCPC: No financial relationships to disclose